FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2102367724> ?p ?o ?g. }

• W2102367724 endingPage "937" @default.
• W2102367724 startingPage "931" @default.
• W2102367724 abstract "Epidermal growth factor inhibition (EGFR) is emerging as an important treatment modality in several epithelial malignancies, including head and neck squamous cell carcinoma (HNSCC). Despite some notable successes, less than 20% of patients respond to EGFR inhibition due to intrinsic and acquired resistance. Since EGFR inhibition is already used for lung, colorectal, breast and pancreas cancers in addition to HNSCC, overcoming treatment resistance would have a major impact on outcome. When the mechanisms of intrinsic resistance are identified, including mutations in the EGFR receptor, alternative therapeutic approaches should be employed. Mechanisms of acquired resistance that may be amenable to pharmacological therapies include dysregulation of EGFR degradation, constitutive activation of overlapping signal transduction pathways, especially cMET/HER3, the PI3K/Akt resistance pathway, angiogenesis and epithelial to mesenchymal transition. COX-2 is another promising target for HNSCC and preclinical data suggest that COX-2 inhibitors can affect most of the described acquired EGFR resistance pathways. Several combined EGFR and COX-2 inhibition trials have been completed and demonstrate promise for HNSCC. Combinatorial strategies of combined inhibition of EGFR and acquired resistance pathways in combination with radiation or chemotherapy are warranted. Keywords: EGFR, COX-2, head and neck cancer, erlotinib, celecoxib, radiation" @default.
• W2102367724 created "2016-06-24" @default.
• W2102367724 creator A5000062139 @default.
• W2102367724 creator A5031579018 @default.
• W2102367724 creator A5064273061 @default.
• W2102367724 date "2009-12-01" @default.
• W2102367724 modified "2023-09-27" @default.
• W2102367724 title "Dual EGFR and COX-2 Inhibition as a Novel Approach to Targeting Head and Neck Squamous Cell Carcinoma" @default.
• W2102367724 cites W1521161473 @default.
• W2102367724 cites W1647640400 @default.
• W2102367724 cites W1938340152 @default.
• W2102367724 cites W1955690499 @default.
• W2102367724 cites W1964099867 @default.
• W2102367724 cites W1964321121 @default.
• W2102367724 cites W1968537403 @default.
• W2102367724 cites W1971450917 @default.
• W2102367724 cites W1976329755 @default.
• W2102367724 cites W1976509817 @default.
• W2102367724 cites W1980256331 @default.
• W2102367724 cites W1982248155 @default.
• W2102367724 cites W1983426670 @default.
• W2102367724 cites W1984389010 @default.
• W2102367724 cites W1990363757 @default.
• W2102367724 cites W1997136340 @default.
• W2102367724 cites W2004439203 @default.
• W2102367724 cites W2005204942 @default.
• W2102367724 cites W2012095617 @default.
• W2102367724 cites W2017249285 @default.
• W2102367724 cites W2023451378 @default.
• W2102367724 cites W2025838546 @default.
• W2102367724 cites W2034855589 @default.
• W2102367724 cites W2040755286 @default.
• W2102367724 cites W2041166427 @default.
• W2102367724 cites W2043707891 @default.
• W2102367724 cites W2050888137 @default.
• W2102367724 cites W2054160636 @default.
• W2102367724 cites W2055468996 @default.
• W2102367724 cites W2060071498 @default.
• W2102367724 cites W2073738021 @default.
• W2102367724 cites W2078066512 @default.
• W2102367724 cites W2081951714 @default.
• W2102367724 cites W2089663915 @default.
• W2102367724 cites W2090460815 @default.
• W2102367724 cites W2091573051 @default.
• W2102367724 cites W2092180337 @default.
• W2102367724 cites W2096410299 @default.
• W2102367724 cites W2100772783 @default.
• W2102367724 cites W2107832538 @default.
• W2102367724 cites W2109296446 @default.
• W2102367724 cites W2109318742 @default.
• W2102367724 cites W2109823193 @default.
• W2102367724 cites W2109960839 @default.
• W2102367724 cites W2112845420 @default.
• W2102367724 cites W2115416676 @default.
• W2102367724 cites W2118113452 @default.
• W2102367724 cites W2118863945 @default.
• W2102367724 cites W2120850551 @default.
• W2102367724 cites W2121831273 @default.
• W2102367724 cites W2123103996 @default.
• W2102367724 cites W2128905862 @default.
• W2102367724 cites W2129497878 @default.
• W2102367724 cites W2131185555 @default.
• W2102367724 cites W2131228625 @default.
• W2102367724 cites W2134989772 @default.
• W2102367724 cites W2136789423 @default.
• W2102367724 cites W2138448256 @default.
• W2102367724 cites W2142899523 @default.
• W2102367724 cites W2148122132 @default.
• W2102367724 cites W2149447281 @default.
• W2102367724 cites W2150272237 @default.
• W2102367724 cites W2155384808 @default.
• W2102367724 cites W2157824687 @default.
• W2102367724 cites W2161875727 @default.
• W2102367724 cites W2161917912 @default.
• W2102367724 cites W2165663767 @default.
• W2102367724 cites W2283851730 @default.
• W2102367724 doi "https://doi.org/10.2174/156800909790192437" @default.
• W2102367724 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20025602" @default.
• W2102367724 hasPublicationYear "2009" @default.
• W2102367724 type Work @default.
• W2102367724 sameAs 2102367724 @default.
• W2102367724 citedByCount "31" @default.
• W2102367724 countsByYear W21023677242012 @default.
• W2102367724 countsByYear W21023677242013 @default.
• W2102367724 countsByYear W21023677242014 @default.
• W2102367724 countsByYear W21023677242015 @default.
• W2102367724 countsByYear W21023677242016 @default.
• W2102367724 countsByYear W21023677242018 @default.
• W2102367724 countsByYear W21023677242020 @default.
• W2102367724 countsByYear W21023677242022 @default.
• W2102367724 crossrefType "journal-article" @default.
• W2102367724 hasAuthorship W2102367724A5000062139 @default.
• W2102367724 hasAuthorship W2102367724A5031579018 @default.
• W2102367724 hasAuthorship W2102367724A5064273061 @default.
• W2102367724 hasConcept C121608353 @default.
• W2102367724 hasConcept C126322002 @default.
• W2102367724 hasConcept C143998085 @default.
• W2102367724 hasConcept C2776530083 @default.

• next